Bookmark
Forward
Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
BMJ case reports 2021 Jul 29Sizes of these terms reflect their relevance to your search.
Omalizumab is an anti-IgE monoclonal antibody used in severe allergic asthma. Herein, we describe a case of eosinophilic granulomatosis with polyangiitis, which manifested 3 months after initiation of omalizumab therapy, while maintenance corticosteroid therapy dose was unchanged. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Citation
Luke Nessan Carson, Ashish Pradhan, Deepak Subramanian. Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence? BMJ case reports. 2021 Jul 29;14(7)
Mesh Tags
Substances
PMID: 34326107
View Full Text
